Clinical-proteomic classification and precision treatment strategy of chordoma

Chordoma is a rare and heterogeneous mesenchymal malignancy, with distinct clinical and biological behaviors. Till now, its comprehensive clinical-molecular characteristics and accurate molecular classification remain obscure. In this research, we enroll 102 patients with chordoma and describe their...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cell reports. Medicine 2024-10, Vol.5 (10), p.101757, Article 101757
Hauptverfasser:	Yin, Huabin, Hu, Jinbo, Gao, Jianxuan, Su, Tong, Jin, Jiali, Jiang, Cong, Yin, Wenxuan, Xu, Xiaowen, Chang, Zhengyan, Sun, Wei, Cai, Zhengdong, Zhou, Wang, Wang, Ping, Lin, Jun, Song, Dianwen, Meng, Tong
Format:	Artikel
Sprache:	eng
Schlagworte:	anlotinib bone tumor chordoma denosumab molecular classification precision treatment strategy proteomic analysis S-Gboxin targeted therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!